Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Clinical trial NCT07232953 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07232953
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT)

Start date: 2022-11-10
Primary completion: 2026-06-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.